PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
March 11, 2024Frontiers in OncologyOpen Access

Management of Trastuzumab Deruxtecan-related nausea and vomiting in real-world practice

View Full Paper
Ask AI
Bookmark
Share

Authors

GNGiulia NotiniMNMatteo Maria NaldiniLSLorenzo Sica

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Notini et al. (2024) studied this question.

synapsesocial.com/papers/68e74937b6db6435876c1976https://doi.org/10.3389/fonc.2024.1374547
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Trastuzumab Deruxtecan in HER2 -Mutant Non–Small-Cell Lung Cancer2021 · 1,025 citations
  2. 2Emetogenicity of Antibody-Drug Conjugates (ADCs) in Solid Tumors with a Focus on Trastuzumab Deruxtecan: Insights from an Italian Expert Panel2022 · 29 citations